CRISPR Therapeutics AG (CRSP) Madison Wilson July 28, 2026 10:07 am ⚠️ No article content returned. Share on: Written by: Madison Wilson Latest Company News
Oriole Resources Mbe Gold Resource Jumps to 1.66 Million Ounces as District-Scale Potential Builds (video) 23 July 2026
CMC Markets: Why Simpler Technology and Global Reach Could Drive Its Next Retail Growth Phase (video) 23 July 2026
EDX Medical Group Targets More Than £2 Million From New Employee Health Screening Service (video) 16 July 2026
Biotech Growth Trust: The biotech rebound powered by innovation, valuations and pharma’s patent cliff 8 July 2026
CMC Markets FY26 Presentation: The Platform Is Built, The Partnerships Are In Place, Now We Scale 12 June 2026
Cerillion Investor Presentation. Substantial Pipeline. Stronger Competitive Position 26 December 2025
RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield 4 December 2025
CMC Markets Presentation: API-Driven Growth Surges as Westpac Deal Ignites Strategic Shift 2 December 2025
Pharos Energy reports high production, strong cash position and further Vietnam drilling progress, Auctus Advisors 20 July 2026
Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover 13 July 2026
Close Brothers Group PLC (CBG.L) Stock Analysis: Navigating Challenges with a Potential 19.44% Upside 29 July 2026
CAPITAL GEARING TRUST PLC ORD 2 (CGT.L) Stock Analysis: Navigating Uncharted Waters with a Market Cap of $819M 29 July 2026
Coats Group PLC (COA.L) Stock Analysis: Unveiling a 41.81% Potential Upside with Robust Buy Ratings 29 July 2026
Cranswick PLC (CWK.L) Stock Analysis: A Consumer Defensive Giant with 15.89% Potential Upside 29 July 2026
Breedon Group PLC (BREE.L) Stock Analysis: Exploring an 18% Upside with Strong Analyst Ratings 29 July 2026
Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover 13 July 2026
